awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38832510-26118DAA-DDD8-42AF-BF08-9A4BFA4082C4
Q38832510-26118DAA-DDD8-42AF-BF08-9A4BFA4082C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38832510-26118DAA-DDD8-42AF-BF08-9A4BFA4082C4
Investigational new drugs for brain cancer.
P2860
Q38832510-26118DAA-DDD8-42AF-BF08-9A4BFA4082C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38832510-26118DAA-DDD8-42AF-BF08-9A4BFA4082C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
485c85da78472b9c0361925c67367e7201ea78b4
P2860
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.